Your browser doesn't support javascript.
loading
Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09).
Oncology ; 89(2): 70-8, 2015.
Article in En | MEDLINE | ID: mdl-25765871

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urologic Neoplasms / Paclitaxel / Urothelium / Everolimus / Antineoplastic Agents Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Oncology Year: 2015 Document type: Article Affiliation country: Germany Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urologic Neoplasms / Paclitaxel / Urothelium / Everolimus / Antineoplastic Agents Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Oncology Year: 2015 Document type: Article Affiliation country: Germany Country of publication: Switzerland